tiprankstipranks
Trending News
More News >
Baudax Bio (BXRXQ)
OTHER OTC:BXRXQ
US Market

Baudax Bio (BXRXQ) Ratios

Compare
745 Followers

Baudax Bio Ratios

BXRXQ's free cash flow for Q3 2023 was $―. For the 2023 fiscal year, BXRXQ's free cash flow was decreased by $ and operating cash flow was $―. See a summary of the company’s cash flow.
Ratios
TTM
Dec 22Dec 21Dec 20Dec 19
Liquidity Ratios
Current Ratio
0.30----
Quick Ratio
0.30----
Cash Ratio
0.25----
Solvency Ratio
-1.65----
Operating Cash Flow Ratio
-1.30----
Short-Term Operating Cash Flow Coverage
-4.96----
Net Current Asset Value
$ -27.93M----
Leverage Ratios
Debt-to-Assets Ratio
0.71----
Debt-to-Equity Ratio
-0.29----
Debt-to-Capital Ratio
-0.42----
Long-Term Debt-to-Capital Ratio
-0.07----
Financial Leverage Ratio
-0.41----
Debt Service Coverage Ratio
-6.00----
Interest Coverage Ratio
0.00----
Debt to Market Cap
16.33K----
Interest Debt Per Share
21.47----
Net Debt to EBITDA
-0.06----
Profitability Margins
Gross Profit Margin
-452.32%----
EBIT Margin
-2816.63%----
EBITDA Margin
-2646.26%----
Operating Profit Margin
-4476.99%----
Pretax Profit Margin
-4633.18%----
Net Profit Margin
-4633.18%----
Continuous Operations Profit Margin
-4633.18%----
Net Income Per EBT
100.00%----
EBT Per EBIT
103.49%----
Return on Assets (ROA)
-586.07%----
Return on Equity (ROE)
1067.45%----
Return on Capital Employed (ROCE)
497.14%----
Return on Invested Capital (ROIC)
974.83%----
Return on Tangible Assets
-743.77%----
Earnings Yield
-1772989762.22%----
Efficiency Ratios
Receivables Turnover
3.79----
Payables Turnover
1.78----
Inventory Turnover
0.00----
Fixed Asset Turnover
1.80----
Asset Turnover
0.13----
Working Capital Turnover Ratio
-0.35----
Cash Conversion Cycle
-108.15----
Days of Sales Outstanding
96.36----
Days of Inventory Outstanding
0.00----
Days of Payables Outstanding
204.50----
Operating Cycle
96.36----
Cash Flow Ratios
Operating Cash Flow Per Share
-83.81----
Free Cash Flow Per Share
-83.87----
CapEx Per Share
0.06----
Free Cash Flow to Operating Cash Flow
1.00----
Dividend Paid and CapEx Coverage Ratio
-1.39K----
Capital Expenditure Coverage Ratio
-1.39K----
Operating Cash Flow Coverage Ratio
-3.90----
Operating Cash Flow to Sales Ratio
-21.90----
Free Cash Flow Yield
-6379128.44%----
Valuation Ratios
Price-to-Earnings (P/E) Ratio
>-0.01----
Price-to-Sales (P/S) Ratio
<0.01----
Price-to-Book (P/B) Ratio
>-0.01----
Price-to-Free Cash Flow (P/FCF) Ratio
>-0.01----
Price-to-Operating Cash Flow Ratio
>-0.01----
Price-to-Earnings Growth (PEG) Ratio
>-0.01----
Price-to-Fair Value
>-0.01----
Enterprise Value Multiple
-0.06----
Enterprise Value
1.86M----
EV to EBITDA
-0.06----
EV to Sales
1.47----
EV to Free Cash Flow
-0.07----
EV to Operating Cash Flow
-0.07----
Tangible Book Value Per Share
-79.52----
Shareholders’ Equity Per Share
-73.10----
Tax and Other Ratios
Effective Tax Rate
0.00----
Revenue Per Share
3.83----
Net Income Per Share
-177.30----
Tax Burden
1.00----
Interest Burden
1.64----
Research & Development to Revenue
3.06----
SG&A to Revenue
0.00----
Stock-Based Compensation to Revenue
1.10----
Income Quality
0.47----
Currency in USD